Review
Open access
Oct 2026
Capturing the Patient Voice: Qualitative Assessment of Daridorexant's Impact on Patients with Insomnia and Comorbid Nocturia from a Randomized, Placebo-Controlled Crossover Trial.
Patients reported meaningful improvements with daridorexant 50 mg, including better sleep, reduced nocturia, and enhanced physical, cognitive, and emotional functioning, highlighting the value of free‑text surveys for capturing patient‑centered outcomes.
Dario Arnaldi, D. L. Bliwise, Duygu Alpan et al.
· Advances in Therapy · 0 citations